Published on 9 Mar 2022 on Benzinga
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit...
Here's a roundup of top developments in the biotech space over the last 24 hours.
AbbVie, Inc. (NYSE: ABBV) and Alvotech announced a settlement agreement that gives Alvotech non-exclusive rights to market AVT01, a biosimilar to AbbVie's Humira, in the U.S. The settlement gives Alvotech a license entry date into the U.S. of July 1, 2023.
NASDAQ.PRTK price evolution
NASDAQ.AMYT price evolution
NASDAQ.PLSE price evolution
NASDAQ.MIRM price evolution
NASDAQ.NRXP price evolution
NASDAQ.ACOR price evolution
NASDAQ.SNY price evolution
NYSE.ABBV price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free